Edition:
United Kingdom

ARCA Biopharma Inc (ABIO.OQ)

ABIO.OQ on NASDAQ Stock Exchange Capital Market

0.50USD
11 Dec 2018
Change (% chg)

-- (--)
Prev Close
$0.50
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
78,177
52-wk High
$1.92
52-wk Low
$0.45

Chart for

About

ARCA biopharma, Inc. (ARCA) is a biopharmaceutical company. The Company is principally focused on developing genetically-targeted therapies for cardiovascular diseases. The Company's lead product candidate is Gencaro (bucindolol hydrochloride), a beta-blocker and mild vasodilator that the Company is evaluating in a clinical... (more)

Overall

Beta: 1.86
Market Cap(Mil.): $19.46
Shares Outstanding(Mil.): 12.97
Dividend: --
Yield (%): --

Financials

  ABIO.OQ Industry Sector
P/E (TTM): -- 31.13 33.63
EPS (TTM): -2.05 -- --
ROI: -82.09 15.55 15.02
ROE: -82.23 16.92 16.60

Earnings vs. Estimates